genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2009
Dowpharma
Bioprocessing
Xcellerex, Dowpharma, Biopharm, and deltaDot Win $11M Technology Development Contract
News
Valeant Continues Efforts to Bolster Dermatology Business with $285M Acquisition of Dow Pharmaceutical Sciences
News
Dr. Reddy’s Picks Up Part of Dowpharma’s Small Molecule Franchise Based in U.K.
News
Dowpharma Licenses Pfenex Expression Technology to Biovel Life Sciences
Insights
Host Strain Development for Proteins
News
Dowpharma Enters into Multiproduct License Agreement with Merck
Insights
Lean and Six Sigma Approaches Taking Hold
Insights
Improving Stability While Adding Value
Scroll Up
Scroll Up
